MedTrace Logo

Uterine Transposition: Feasibility Study

NCT03040921 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2022-01-11

No results posted yet for this study

Summary

This prospective nonrandomized multicenter phase I study, will evaluate the feasibility of performing uterine transposition before chemoradiation for rectal cancer and uterine reimplantation after the treatment.

Conditions

  • Postoperative Complications
  • Intraoperative Complications
  • Tissue Damage
  • Ovarian Failure
  • Uterus Disorder

Interventions

PROCEDURE

Uterine transposition.

Surgical transposition of the uterus to the upper abdomen. After the end of radiotherapy, rectosigmoidectomy is performed and the uterus is repositioned into the pelvis.

Sponsors & Collaborators

  • Hospital Erasto Gaertner

    lead OTHER

Principal Investigators

  • Reitan Ribeiro, MD · Erasto Gaertner Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-06-01
Completion
2021-04-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03040921 on ClinicalTrials.gov